Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Article in Portuguese | LILACS-Express | LILACS | ID: biblio-1537807

ABSTRACT

As Infecções Relacionadas à Assistência à Saúde (IRAS) ocorrem com mais frequência em Unidade de Terapia Intensiva (UTI) devido a exposição maior dos pacientes a procedimentos e dispositivos invasivos, quadro clínico debilitado e sua manipulação pela equipe assistencial exigindo uso elevado de antimicrobianos, o que pode promover um risco de desenvolvimento de resistência bacteriana a estes, cujas consequências podem ser a dificuldade de tratamento, internamento prolongado, risco de óbito e maior custo associado. Tem como objetivo descrever as IRAs relacionando os agentes etiológicos e o tratamento antimicrobiano em uma UTI de um hospital de referência da mesorregião do Rio Grande do Norte. Trata-se de um estudo descritivo, retrospectivo e transversal de abordagem quantitativa. Foram inseridos 1.682 pacientes internados na UTI geral do hospital estudado entre 2017-2020. Os dados foram coletados a partir de fichas de registro que foram tabuladas e analisadas nos softwares Microsoft Office Excel® e Statistical Package for the Social Sciences utilizando estatística descritiva simples com apresentação de frequências, tendências e dispersão. A análise dos resultados revelou mediana de idade de 57 anos, prevalência do sexo masculino e existência de comorbidades em 57,9% dos casos, especialmente infecção prévia a admissão na UTI. O tempo médio de permanência na UTI foi 11,4 dias e taxa de mortalidade de 52%. Quanto aos dispositivos invasivos, observou-se uso de sonda vesical de demora (96,8%), ventilação mecânica (79,4%) e cateter venoso central (83,7%). Constatou-se 790 IRAS da UTI com crescimento bacteriano em 48,2%. As principais densidades de incidência (DI) de IRAS/1.000 pacientes-dia foram: IPCSL-CVC 1,8; PAV 27 e ITU-AC 22,3. Quanto aos antibióticos, observou-se Lenght of therapy de 872,5/1.000 pacientes-dia, sendo os mais prescritos: vancomicina (N=633), meropenem (N=625), ceftriaxona (N=479), amicacina (N=463) e polimixina B (N=448). Os valores destaques de Days of therapy/1.000 pacientes-dia: meropenem (N=305,7), amicacina (N=260,4), polimixina B (N=256,4), vancomicina (N=229,3) e imipenem (N=165,3). As bactérias mais isoladas nas culturas foram: Acinetobacter spp., Pseudomonas spp. e Klebsiella spp., as quais apresentaram resistência, principalmente, a: ceftazidima (51,5% - 87,3%); cefepima (61,6% - 85,3%); ciprofloxacino (56% - 84,6%) e meropenem (31,7% - 80,3%). Identificou-se não conformidades no tratamento com antibióticos em 455 pacientes, que envolvem principalmente polimixina B, vancomicina, meropenem e ceftriaxona. Conclui-se que há elevados níveis de tempo de permanência na UTI e uso de dispositivos invasivos, assim como DI de IRAS alta com identificação microbiológica de bactérias importantes, especialmente por seu perfil de resistência acentuado com destaque para antibióticos da classe dos carbapenêmicos e cefalosporinas de 3a e 4a geração. Destaca-se também a presença de não conformidades na administração de antibióticos que podem contribuir para a seleção de bactérias multirresistentes.


Health Care-Related Infections (HAI) occur more frequently in the Intensive Care Unit (ICU) due to the greater exposure of patients to invasive procedures and devices, weakened clinical status and their handling by the care team, requiring high use of antimicrobials, which can promote a risk of developing bacterial resistance to these, whose consequences may be difficult treatment, prolonged hospitalization, risk of death and higher associated costs. It aims to describe the IRAS relating the etiological agents and antimicrobial treatment in an ICU of a reference hospital in the mesoregion of Rio Grande do Norte. This is a descriptive, retrospective and cross-sectional study with a quantitative approach. A total of 1,682 patients admitted to the general ICU of the hospital studied between 2017-2020 were included. Data were collected from registration forms that were tabulated and analyzed in Microsoft Office Excel® and Statistical Package for the Social Sciences software using simple descriptive statistics with presentation of frequencies, trends and dispersion. The analysis of the results revealed a median age of 57 years, prevalence of males and the existence of comorbidities in 57.9% of cases, especially infection prior to admission to the ICU. The average length of stay in the ICU was 11.4 days and the mortality rate was 52%. As for invasive devices, the use of an indwelling urinary catheter (96.8%), mechanical ventilation (79.4%) and central venous catheter (83.7%) was observed. There were 790 IRAS in the ICU with bacterial growth in 21.67%. The main HAI incidence densities (DI)/1,000 patient-days were: IPCSL-CVC 1.8; PAV 27 and UTI-AC 22.3. As for antibiotics, a Length of therapy of 872.5/1,000 patient-days was observed, with the most prescribed being: vancomycin (N=633), meropenem (N=625), ceftriaxone (N=479), amikacin (N= 463) and polymyxin B (N=448). The highlighted values of Days of therapy/1000 patient-days: meropenem (N=305.7), amikacin (N=260.4), polymyxin B (N=256.4), vancomycin (N=229.3) and imipenem (N=165.3). The most isolated bacteria in cultures were: Acinetobacter spp., Pseudomonas spp. and Klebsiella spp., which showed resistance mainly to: Ceftazidime (51.5% - 87.3%); cefepime (61.6% - 85.3%); ciprofloxacin (56% - 84.6%) and meropenem (31.7% - 80.3%). Non-compliance was identified in the treatment with antibiotics in 455 patients, which mainly involve polymyxin B, vancomycin, meropenem and ceftriaxone. It is concluded that there are high levels of ICU length of stay and use of invasive devices, as well as high IRAS ID with microbiological identification of important bacteria, especially due to their accentuated resistance profile, with emphasis on antibiotics from the carbapenem class and cephalosporins from 3rd and 4th generation. Also noteworthy is the presence of non-compliance in the administration of antibiotics that may contribute to the selection of multidrug-resistant bacteria.


Las Infecciones Relacionadas con la Atención de la Salud (IRAS) ocurren con mayor frecuencia en la Unidad de Cuidados Intensivos (UCI) debido a la mayor exposición de los pacientes a procedimientos y dispositivos invasivos, el debilitamiento del estado clínico y su manejo por parte del equipo asistencial, requiriendo un alto uso de antimicrobianos , lo que puede promover un riesgo de desarrollar resistencia bacteriana a estos, cuyas consecuencias pueden ser un tratamiento difícil, hospitalización prolongada, riesgo de muerte y mayores costos asociados. Tiene como objetivo describir las IRAs que relacionan los agentes etiológicos y el tratamiento antimicrobiano en una UTI de un hospital de referencia en la mesorregión de Rio Grande do Norte. Se trata de un estudio descriptivo, retrospectivo y transversal con enfoque cuantitativo. Se incluyeron un total de 1.682 pacientes ingresados en la UCI general del hospital estudiado entre 2017-2020. Los datos fueron recolectados a partir de formularios de registro que fueron tabulados y analizados en el software Microsoft Office Excel® y Statistical Package for the Social Sciences utilizando estadística descriptiva simple con presentación de frecuencias, tendencias y dispersión. El análisis de los resultados reveló una mediana de edad de 57 años, predominio del sexo masculino y la existencia de comorbilidades en el 57,9% de los casos, especialmente infección previa al ingreso en UCI. La estancia media en la UCI fue de 11,4 días y la tasa de mortalidad fue del 52%. En cuanto a los dispositivos invasivos, se observó el uso de catéter urinario permanente (96,8%), ventilación mecánica (79,4%) y catéter venoso central (83,7%). Había 790 IRAS en la UCI con crecimiento bacteriano en el 48,2%. Las principales densidades de incidencia (DI) de IRAS/1.000 pacientes-día fueron: IPCSL-CVC 1,8; PAV 27 y UTI-AC 22.3. En cuanto a los antibióticos, se observó una Duración de la terapia de 872,5/1.000 días-paciente, siendo los más prescritos: vancomicina (N=633), meropenem (N=625), ceftriaxona (N=479), amikacina (N= 463) y polimixina B (N=448). Los valores destacados de Días de terapia/1.000 pacientes-día: meropenem (N=305,7), amikacina (N=260,4), polimixina B (N=256,4), vancomicina (N=229,3) e imipenem (N=165,3). Las bacterias más aisladas en cultivos fueron: Acinetobacter spp., Pseudomonas spp. y Klebsiella spp., que mostraron resistencia principalmente a: ceftazidima (51,5% - 87,3%); cefepima (61,6% - 85,3%); ciprofloxacino (56% - 84,6%) y meropenem (31,7% - 80,3%). Se identificó incumplimiento en el tratamiento con antibióticos en 455 pacientes, los cuales involucran principalmente polimixina B, vancomicina, meropenem y ceftriaxona. Se concluye que existen altos índices de estancia en UCI y uso de dispositivos invasivos, así como elevado IRAS ID con identificación microbiológica de bacterias importantes, especialmente por su acentuado perfil de resistencia, con énfasis en antibióticos de la clase carbapenémicos y cefalosporinas de 3ra y 4ta generación. También es destacable la presencia de incumplimiento en la administración de antibióticos que pueden contribuir a la selección de bacterias multirresistentes.

2.
Rev. epidemiol. controle infecç ; 13(3): 130-136, jul.-set. 2023. ilus
Article in English | LILACS | ID: biblio-1531862

ABSTRACT

Background and objectives: colonization by extended-spectrum ß-lactamase (ESBL)-producing Klebsiella pneumoniae in Intensive Care Unit (ICU) patients is considered a risk factor for infections, and poses as a source of spreading these strains in hospital facilities. This study aimed to perform the genetic characterization of ESBL-producing K. pneumoniae isolates recovered from surveillance swabs in an ICU in northeastern Brazil. Methods: the isolates were recovered between 2018-2019 from the nasal, axillary, and rectal sites of 24 patients admitted to the ICU. Bacterial identification was performed by traditional biochemical tests. Antimicrobial susceptibility was assessed by disk diffusion, and ESBL phenotype was detected by double-disc synergy test. Polymerase chain reaction (PCR) for blaCTX-M, blaSHV, and blaTEM genes, PFGE, and MLST were carried out in representative isolates. Results: a total of 27 isolates were recovered from 18 patients (75%). The ESBL production was detected in 85% of isolates. Resistance to ciprofloxacin, sulfamethoxazole/trimethoprim and most of the ß-lactams tested was recurrent, except for carbapenems. The blaSHV, blaTEM, and blaCTX-M genes were found in high frequency, and the CTX-M-(1, 2 and 9) groups were identified. Seven sequence types (ST11, ST14, ST17, ST395, ST709, ST855, and ST3827) were described, most of them considered high-risk. Conclusion: these findings emphasize the potential threat of well-established high-risk clones in an ICU, and highlight the importance of monitoring these clones to prevent infections.(AU)


Justificativa e objetivos: a colonização por Klebsiella pneumoniae produtora de ß-lactamase de espectro estendido (ESBL) em pacientes de Unidade de Terapia Intensiva (UTI) é considerada um fator de risco para infecções, e representa uma fonte de disseminação dessas cepas em instalações hospitalares. Este estudo objetivou realizar a caracterização genética de isolados de K. pneumoniae produtores de ESBL recuperados de swabs de vigilância em uma UTI no Nordeste do Brasil. Métodos: os isolados foram recuperados entre 2018-2019 dos sítios nasal, axilar e retal de 24 pacientes internados na UTI. A identificação bacteriana foi realizada por testes bioquímicos tradicionais. A suscetibilidade antimicrobiana foi avaliada por disco-difusão, e o fenótipo ESBL foi detectado pelo teste de sinergia de duplo-disco. Polymerase chain reaction (PCR) para os genes blaCTX-M, blaSHV e blaTEM, PFGE e MLST foram realizados em isolados representativos. Resultados: foram recuperados 27 isolados de 18 pacientes (75%). A produção de ESBL foi detectada em 85% dos isolados. A resistência à ciprofloxacina, sulfametoxazol/trimetoprima e à maioria dos ß-lactâmicos testados foi recorrente, exceto para os carbapenêmicos. Os genes blaSHV, blaTEM e blaCTX-M foram encontrados em alta frequência, e os grupos CTX-M-(1, 2 e 9) foram identificados. Sete sequence types (ST11, ST14, ST17, ST395, ST709, ST855 e ST3827) foram descritos, a maioria deles considerados de alto risco. Conclusão: esses achados enfatizam a ameaça potencial de clones de alto risco bem estabelecidos em uma UTI, e destacam a importância do monitoramento desses clones para prevenir infecções.(AU)


Justificación y objetivos: la colonización por Klebsiella pneumoniae productora de ß-lactamasas de espectro extendido (BLEE) en pacientes de Unidades de Cuidados Intensivos (UCI) se considera un factor de riesgo para infecciones, y se presenta como una fuente de propagación de estas cepas en instalaciones hospitalarias. Este estudio tuvo como objetivo realizar la caracterización genética de aislamientos de K. pneumoniae productores de BLEE recuperados de hisopos de vigilancia en una UCI en el noreste de Brasil. Métodos: los aislamientos se recuperaron entre 2018-2019 de sitios nasales, axilares y rectales de 24 pacientes ingresados en la UCI. La identificación bacteriana se realizó mediante pruebas bioquímicas tradicionales. La susceptibilidad antimicrobiana se evaluó mediante difusión en disco, y el fenotipo BLEE se detectó mediante la prueba de sinergia de doble-disco. La polymerase chain reaction (PCR) para los genes blaCTX-M, blaSHV y blaTEM, PFGE y MLST se llevaron a cabo en aislamientos representativos. Resultados: se recuperaron 27 aislamientos de 18 pacientes (75%). La producción de ESBL se detectó en 85% de los aislamientos. La resistencia a ciprofloxacino, sulfametoxazol/trimetoprima y a la mayoría de los ß-lactámicos evaluados fue recurrente, excepto a los carbapenémicos. Los genes blaSHV, blaTEM y blaCTX-M se encontraron en alta frecuencia, y se identificaron los grupos CTX-M-(1, 2 y 9). Se describieron siete sequence types (ST11, ST14, ST17, ST395, ST709, ST855 y ST3827), la mayoría consideradas de alto riesgo. Conclusión: estos hallazgos enfatizan la amenaza potencial de los clones de alto riesgo bien establecidos en una UCI, y resaltan la importancia de monitorear estos clones para prevenir infecciones.(AU)


Subject(s)
Humans , beta-Lactamases , Clone Cells , Intensive Care Units , Klebsiella pneumoniae/genetics , Drug Resistance , Cross Infection/prevention & control
3.
Rev. ABENO ; 23(1): 1976, mar. 2023. ilus, tab
Article in Portuguese | BBO - Dentistry | ID: biblio-1525057

ABSTRACT

O objetivo deste estudo foi investigar, por meio de uma revisão de literatura, a utilização da realidade virtual no processo de ensino-aprendizagem da graduação em Odontologia. Trata-se de um estudo de revisão integrativa da literatura, com buscas de alta sensibilidade, realizado nas bases de dados Medline (PubMed), EMBASE (Elsevier), Cochrane Library e Biblioteca Virtual em Saúde, utilizando-se descritores relacionados à realidade virtual, ensino na Odontologia e educação, com termos correlatos recuperados no MeSH, DeCS e Emtree. A busca foi realizada em maio de 2022 por ensaios clínicos nas línguas portuguesa, inglesa ou espanhola. Após avaliação por meio dos critérios de inclusão e exclusão estabelecidos, 14 ensaios clínicos, publicados entre os anos de 2004 e 2021 em língua inglesa, foram incluídos. As finalidades mais testadas das tecnologias de realidade virtual foram para preparos cavitários para remoção de cárie (n=7) e no ensino teórico (n=2). Quanto aos instrumentos de avaliação dos participantes, a avaliação prática de destreza manual foi a mais usada (n=9). As limitações mais recorrentes (n=6) foram deficiências na avaliação ou nos métodos avaliativos dos estudos. Assim, conclui-se que a utilização da realidade virtual na área da Odontologiaapresenta o potencial de aprimorar habilidades técnicas e complementar o ensino de assuntos teóricos de disciplinas da graduação. Considerando esse potencial, sugere-se que mais estudos sejam realizados para uma melhor eficácia e aplicabilidade da realidade virtual na graduação (AU).


El objetivo de este estudio fue investigar, a través de una revisión de la literatura, el uso de la realidad virtual en el proceso de enseñanza-aprendizaje de la carrera de Odontología. Se trata de un estudio de revisión integradora de la literatura, con búsquedas de alta sensibilidad, realizado en las bases de datos Medline (PubMed), EMBASE (Elsevier), Biblioteca Cochrane y Biblioteca Virtual en Salud, utilizando descriptores relacionados con la realidad virtual, la enseñanza en Odontología y la educación, con temas relacionados. términos recuperados de MeSH, DeCS y Emtree. La búsqueda se realizó en mayo de 2022 de ensayos clínicos en portugués, inglés o español. Tras la evaluación mediante los criterios de inclusión y exclusión establecidos, se incluyeron 14 ensayos clínicos, publicados entre 2004 y 2021 en inglés. Los usos más probados de las tecnologías de realidad virtual fueron la preparación de cavidades para la eliminación de caries (n=7) y la enseñanza teórica (n=2). En cuanto a los instrumentos de evaluación de los participantes, la evaluación práctica de la destreza manual fue la más utilizada (n=9). Las limitaciones más recurrentes (n=6) fueron deficiencias en la evaluación o métodos de evaluación de los estudios. Así, se concluye que el uso de la realidad virtual en el área de Odontología tiene el potencial de mejorar las habilidades técnicas y complementar la enseñanza de materias teóricas en los cursos de pregrado. Considerando este potencial, se sugiere realizar más estudios para mejorarla efectividad y aplicabilidad de la realidad virtual en los estudios de pregrado (AU).


The objective of this study was to investigate, through a literature review, the use of virtual reality in the teaching-learning process of undergraduate Dentistry. This is an integrative literature review study, with high sensitivity searches, carried out in the Medline (PubMed), EMBASE (Elsevier), Cochrane Library and Virtual Health Library databases, using descriptors related to virtual reality, teaching in Dentistry and education, with related terms retrieved from MeSH, DeCS and Emtree. The search was carried out in May 2022 for clinical trials in Portuguese, English or Spanish.After evaluation using the established inclusion and exclusion criteria, 14 clinical trials, published between 2004 and 2021 in English, were included. The most tested purposes of virtual reality technologies were for cavity preparations for caries removal (n=7) and in theoretical teaching (n=2). Regarding participant assessment instruments, the practical assessment of manual dexterity was the most used (n=9). The most recurrent limitations (n=6) were deficiencies in the evaluation or evaluation methods ofthe studies. Thus, it is concluded that the use of virtual reality in the area of Dentistry has the potential to improve technical skills and complement the teaching of theoretical subjects in undergraduate courses. Considering this potential, it is suggested that more studies be carried out to improve the effectiveness and applicability of virtual reality in undergraduate studies (AU).


Subject(s)
Teaching , Education, Dental , Educational Technology , Health Human Resource Training
4.
Sci Rep ; 12(1): 9354, 2022 06 07.
Article in English | MEDLINE | ID: mdl-35672430

ABSTRACT

During a microbiological and genomic surveillance study conducted to investigate the molecular epidemiology of extended-spectrum ß-lactamase (ESBL)-producing Escherichia coli from community-acquired urinary tract infections (UTI) and commercial meat samples, in a Brazilian city with a high occurrence of infections by ESBL-producing bacteria, we have identified the presence of CTX-M (-2, -14, -15, -24, -27 and -55)-producing E. coli of international clones ST38, ST117, ST131 and ST354. The ST131 was more prevalent in human samples, and worryingly the high-risk ST131-C1-M27 was identified in human infections for the first time. We also detected CTX-M-55-producing E. coli ST117 from meat samples (i.e., chicken and pork) and human infections. Moreover, the clinically relevant CTX-M-24-positive E. coli ST354 clone was detected for the first time in human samples. In summary, our results highlight a potential of commercialized meat as a reservoir of high-priority E. coli lineages in the community, whereas the identification of E. coli ST131-C1-M27 indicates that novel pandemic clones have emerged in Brazil, constituting a public health issue.


Subject(s)
Community-Acquired Infections , Escherichia coli Infections , Anti-Bacterial Agents , Brazil/epidemiology , Clone Cells , Community-Acquired Infections/epidemiology , Community-Acquired Infections/microbiology , Escherichia coli/genetics , Escherichia coli Infections/epidemiology , Escherichia coli Infections/microbiology , Genomics , Humans , Meat , beta-Lactamases/genetics
5.
Rev. med (São Paulo) ; 101(3): e-183634, 2022.
Article in English, Portuguese | LILACS-Express | LILACS | ID: biblio-1392295

ABSTRACT

Apesar do uso de plantas medicinais para tratamento de problemas de saúde ser tradicionalmente aceito, esta prática da medicina popular ainda encontra resistência por profissionais da saúde, sobretudo sob a alegação da falta de comprovação de seus efeitos. Durante o surto de Covid-19, houve aumento significativo do estresse, sintomas ansiosos e insônia e o uso de plantas medicinais e fitoterápicos surge como uma alternativa terapêutica. O objetivo deste estudo foi realizar uma revisão da literatura sobre a eficácia de plantas medicinais como terapia alternativa e/ou complementar para transtornos de ansiedade e insônia. As plantas investigadas foram selecionadas a partir do Formulário de Fitoterápicos e Memento Fitoterápico da Farmacopeia Brasileira, sendo utilizados como descritores o nome científico da planta e os termos "anxiety" e "insomnia" com recorte temporal de 2015 a 2020. 230 resultados foram encontrados, 42 selecionados (27 em humanos e 15 em animais). Foi possível demonstrar efeitos ansiolíticos para as plantas capim santo (Cymbopogon citratus), lavanda (Lavandula officinalis), melissa (Melissa officinalis), maracujá (Passiflora incarnata)e valeriana (Valeriana officinalis) e sedativos para melissa, maracujá e valeriana. A kava-kava (Piper methysticum) demonstrou apenas efeito sedativo e a camomila (Matricaria chamomilla) apresentou eficácia clínica ansiolítica. Portanto, a potencial aplicação clínica dessas plantas é indicada para tratamento dos sintomas de ansiedade e insônia, ajudando a reduzir os sintomas psicológicos decorrentes da pandemia de Covid-19. Contudo, vale ressaltar a necessidade da padronização dos procedimentos metodológicos e avanço da fitoterapia na prática médica. [au]


Although the use of medicinal plants to treat health problems is traditionally accepted, this practice of popular medicine still finds resistance from health professionals, especially under the allegation of lack of scientific proof of its effects. During the outbreak of COVID-19, there was a significant increase in stress, anxiety, and insomnia symptoms, and the use of plants and herbal medicines emerged as a possible therapeutic alternative. The objective of this study was to conduct a literature review about the effectiveness of medicinal plants as an alternative and/or complementary therapy for anxiety and insomnia disorders. The main medicinal plants were selected from the Phytotherapeutic Formulary and Phytotherapeutic Memento of the Brazilian Pharmacopoeia, using the 'scientific name' and terms 'anxiety' and 'insomnia' as descriptors between 2015-2020. 230 results were found and 42 studies were selected (27 in humans and 15 in animals). Anxiolytic effects have been demonstrated to Cymbopogon citratus, Lavandula officinalis, Melissa officinalis, Passiflora incarnata, and Valeriana officinalis and sedatives effects to M. officinalis, P. incarnata, and V. officinalis. Piper methysticum revealed only a sedative effect and Matricaria chamomilla showed anxiolytic clinical efficacy. Then, the potential clinical application of these plants in the treatment of anxiety and insomnia symptoms is indicated, helping to reduce the psychological symptoms resulting from the Covid-19 pandemic. However, it is worth emphasizing the need to standardize methodological procedures and advance phytotherapy in medical practice. [au]

6.
Microb Drug Resist ; 26(6): 652-660, 2020 Jun.
Article in English | MEDLINE | ID: mdl-31851584

ABSTRACT

KPC-producing Klebsiella pneumoniae (KPC-Kp) has become an important public health issue. The previous intestinal colonization by KPC-Kp has been an important risk factor associated with the progression to infections. The objective of this study was to assess the genetic characterization of KPC-Kp isolates recovered from human rectal swabs in Brazil. We selected 102 KPC-Kp isolates collected during 2009-2013 in 11 states. Antimicrobial susceptibility was determined by disk diffusion, E-test, and broth microdilution. The resistance and virulence genes were investigated by PCR. Molecular typing was performed by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). The isolates were mostly resistant to ß-lactams, sulfonamides, chloramphenicol, quinolones, and aminoglycosides but susceptible to fosfomycin/trometamol, polymyxin B, and tigecycline. The blaKPC-2 was mostly associated with Tn4401b. Besides that, the isolates carried blaCTX-M, blaSHV, blaTEM, and aac(6')-Ib in high frequency and aac(3')IIa and qnr genes in moderate frequency. The PFGE revealed 26 pulsotypes and MLST performed in representative strains revealed 23 sequence types, 45% belonging to clonal complex 258 (CC258). Isolates of CC258 were found in all states. Seventy percent of the 102 KPC-Kp isolates belonged to CC258-associated pulsotypes. We describe the dissemination of KPC-2-Kp associated with Tn4401b belonging to CC258 colonizing patients in Brazil, which is also prevalent in infected patients, suggesting a clear colonization-infection correlation.


Subject(s)
Anti-Bacterial Agents/pharmacology , Carbapenem-Resistant Enterobacteriaceae/drug effects , Carbapenem-Resistant Enterobacteriaceae/genetics , Drug Resistance, Multiple, Bacterial/genetics , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/genetics , Brazil/epidemiology , Drug Resistance, Bacterial , Electrophoresis, Gel, Pulsed-Field , Genes, Bacterial , Humans , Klebsiella pneumoniae/isolation & purification , Microbial Sensitivity Tests , Molecular Typing , Multilocus Sequence Typing
7.
Microb Drug Resist ; 25(3): 394-399, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30676240

ABSTRACT

New Delhi metallo-ß-lactamase (NDM)-producing bacteria have been identified at a worrying rate in Brazil since 2013. Owing to the need to understand the extent of their spread, this study reports the dissemination of blaNDM in different species of Gram-negative bacilli in different regions and states of Brazil. A total of 81 isolates from nine states were studied, including 11 species. All isolates carried blaNDM-1 variant and were considered multidrug resistant. Colistin and amikacin were the agents with higher activity compared with the other drugs tested. The findings indicate that the NDM-1 enzyme is already widespread in the country.


Subject(s)
Gram-Negative Bacteria/genetics , Gram-Negative Bacteria/isolation & purification , Gram-Negative Bacterial Infections/epidemiology , beta-Lactamases/genetics , Amikacin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Brazil/epidemiology , Colistin/therapeutic use , Drug Resistance, Multiple, Bacterial/genetics , Gram-Negative Bacterial Infections/drug therapy , Gram-Negative Bacterial Infections/microbiology , Humans , Microbial Sensitivity Tests/methods , Tertiary Care Centers
10.
Article in English | MEDLINE | ID: mdl-28167564

ABSTRACT

We characterized NDM-1-producing Klebsiella isolates from Rio de Janeiro, Brazil. PCR was applied for resistance and virulence determinants. The genetic context of blaNDM was determined by S1 nuclease pulsed-field gel electrophoresis (PFGE) and hybridization. Genotyping was performed by PFGE and multilocus sequence typing (MLST). Most isolates carried multiple resistance genes and remained susceptible to amikacin, fosfomycin-trometamol, polymyxin B, and tigecycline. The spread of NDM-1-producing Klebsiella pneumoniae was not associated with clonal expansion and appears to be associated with Tn3000.


Subject(s)
Anti-Bacterial Agents/pharmacology , DNA Transposable Elements , Drug Resistance, Multiple, Bacterial/genetics , Klebsiella pneumoniae/genetics , beta-Lactamases/genetics , Amikacin/pharmacology , Bacterial Typing Techniques , Brazil/epidemiology , Clone Cells , Electrophoresis, Gel, Pulsed-Field , Fosfomycin/pharmacology , Gene Expression , Genotype , Humans , Klebsiella Infections/epidemiology , Klebsiella Infections/microbiology , Klebsiella Infections/transmission , Klebsiella pneumoniae/classification , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/isolation & purification , Minocycline/analogs & derivatives , Minocycline/pharmacology , Multilocus Sequence Typing , Phylogeny , Plasmids/chemistry , Plasmids/metabolism , Polymyxin B/pharmacology , Tigecycline , beta-Lactamases/metabolism
12.
Antimicrob Agents Chemother ; 60(11): 6969-6972, 2016 11.
Article in English | MEDLINE | ID: mdl-27620478

ABSTRACT

We aimed to investigate polymyxin B (PMB) resistance and its molecular mechanisms in 126 Klebsiella pneumoniae isolates from rectal swabs in Brazil. Ten isolates exhibited PMB resistance with interruption of mgrB gene by insertion sequences or missense mutations. Most of the PMB-resistant isolates harbored blaKPC-2 (n = 8) and belonged to clonal complex 258 (CC258) (n = 7). These results highlight the importance of monitoring the spread of polymyxin-resistant bacteria in hospitals, since few options remain to treat multidrug-resistant isolates.


Subject(s)
Bacterial Proteins/genetics , Drug Resistance, Bacterial/genetics , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/genetics , Polymyxin B/pharmacology , Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial/drug effects , Humans , Klebsiella Infections/microbiology , Klebsiella pneumoniae/isolation & purification , Microbial Sensitivity Tests , Mutation , Rectum/microbiology , beta-Lactamases/genetics
13.
Antimicrob Agents Chemother ; 59(8): 4453-6, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25987619

ABSTRACT

Enzymes of the OXA-48 family have become some of the most important beta-lactamases in the world. A new OXA-48 variant (OXA-370) was first described for an Enterobacter hormaechei strain isolated in Rio Grande do Sul (southern region of Brazil) in 2013. Here we report detection of the blaOXA-370 gene in 24 isolates belonging to three Enterobacteriaceae species (22 Klebsiella pneumoniae isolates, 1 Enterobacter cloacae isolate, and 1 Enterobacter aerogenes isolate) collected from five hospitals in Rio de Janeiro, Brazil, in 2013 and 2014. The isolates showed a multidrug resistance profile, and 12.5% were resistant to polymyxin B. Besides blaOXA-370, no other carbapenemase genes were observed by PCR, whereas blaOXA-1 was found in all isolates and 22 isolates (91.6%) possessed blaCTX-M-15. Molecular typing of the K. pneumoniae isolates by pulsed-field gel electrophoresis (PFGE) showed the presence of two clonal groups, i.e., KpA (21 isolates) and KpB (1 isolate). KpA was characterized as sequence type 16 (ST16) and KpB as ST1041 by multilocus sequence typing (MLST). ST16 has been observed for KPC-producing K. pneumoniae in Rio de Janeiro. Plasmid analysis performed with six representative OXA-370-producing isolates showed plasmids harboring the blaOXA-370 gene in all strains, ranging from 25 kb to 150 kb. This study suggests that there is an urgent need to investigate the presence of OXA-370 and dissemination of the K. pneumoniae ST16 clone carrying this gene in Brazil.


Subject(s)
Klebsiella Infections/microbiology , Klebsiella pneumoniae/genetics , Klebsiella pneumoniae/isolation & purification , beta-Lactamases/genetics , Bacterial Proteins/genetics , Bacterial Typing Techniques/methods , Brazil , Drug Resistance, Multiple, Bacterial/genetics , Plasmids/genetics
14.
Clin Interv Aging ; 8: 1347-51, 2013.
Article in English | MEDLINE | ID: mdl-24124357

ABSTRACT

OBJECTIVE: The aim of the study reported here was to determine the prevalence of vitamin D deficiency among elderly men and its association with sun exposure and skin phototypes. SUBJECTS AND METHODS: This was an analytical cross-sectional study, which involved 284 men aged 60 years or over, randomly recruited from a basic care unit in the city of Recife (Brazil). MEASUREMENTS: Serum levels of 25 hydroxyvitamin D (25(OH)D), sun index, and skin phototypes were evaluated. RESULTS: The prevalence of vitamin D deficiency was 31.5% and 66.7% when cut points of less than 20 and 30 ng/mL, respectively, were used. Mean serum 25(OH)D was 27.86 ± 13.52 standard deviation (SD) ng/mL. There was no difference (P = 0.113) in 25(OH) D (23.98 ± 14.66 SD vs 29.88 ± 13.78 SD) between individuals in the lowest quartile (Q) of the sun index (Q1: 1.96) compared with those in the highest (Q4: 7.86). When considering a cutoff of 20 ng/mL, the sun index was different in the two groups (P = 0.006), but there was no difference when cutoffs of 25 and 30 ng/mL were used. After adjustment, sun index and body mass index were associated positively and negatively, respectively with serum 25(OH)D independently. Most subjects (66.7%) had Fitzpatrick's skin phototypes IV, V, and VI. Low calcium intake was observed in 72%. There was no difference in serum 25(OH)D levels between patients with low intake and those with intermediate and high intakes. Only 2.5% were taking a vitamin supplement. CONCLUSION: We found a high prevalence of vitamin D deficiency among elderly men despite their high sun exposure during the summer months.


Subject(s)
Seasons , Skin Pigmentation , Sunlight , Tropical Climate , Vitamin D Deficiency/epidemiology , Aged , Body Mass Index , Brazil/epidemiology , Humans , Male , Middle Aged , Prevalence
SELECTION OF CITATIONS
SEARCH DETAIL
...